PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHeiq Regulatory News (HEIQ)

Share Price Information for Heiq (HEIQ)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 13.00
Bid: 13.00
Ask: 14.10
Change: -0.075 (-0.57%)
Spread: 1.10 (8.462%)
Open: 13.00
High: 13.00
Low: 13.00
Prev. Close: 13.075
HEIQ Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

HeiQ Viroblock Partnership with Berger Paint

11 Mar 2021 07:00

RNS Number : 8624R
HeiQ PLC
11 March 2021
 

 

This article is not intended to be distributed in the USA.

 

 

11 March 2021

 

HeiQ Plc

("HeiQ" or "the Company")

 

HeiQ Viroblock Partnership with Berger Paint

 

HeiQ (LSE:HEIQ), an established global brand in materials and textile innovation which operates in high-growth markets, is pleased to announce that it has signed an agreement with global luxury paint provider Berger Paints India Ltd ("Berger"), among the largest 15 paint companies in the world. Berger will produce an innovative antiviral paint, Silk Breathe Easy, which will be powered by HeiQ Viroblock, proven to destroy over 99.99% of infectious viruses and bacteria.

 

The agreement will deliver US$600,000 of revenue to HeiQ for the first year, during which Berger will have exclusivity in India, with potential for significant additional future revenues. The exclusivity term also has the potential to be extended by HeiQ.

 

This partnership is in line with HeiQ's strategy to innovate in and beyond textiles, eventually becoming a global leader in materials innovation. This is the first time that HeiQ Viroblock, which won the prestigious Swiss Technology Award in 2020, will be used in the paints & coatings industry, opening up an exciting new market opportunity for HeiQ, which is dominated by Akzo Nobel, PPG and Sherwin Williams.

 

Silk Breathe Easy is a luxury interior paint designed to give walls a rich appearance, to significantly reduce pollution and to protect by preventing surface transmission of diseases caused by bacteria and viruses. It is designed to enhance hygiene and reduce the risk of contamination in households, public and semi-public spaces. It can also be used in hygiene-sensitive environments such as surgical theaters and other medical and healthcare facilities. Formulated with 100% acrylic emulsions and vibrant pigments, it has low volatile organic compound ("VOC") and has formaldehyde reduction abilities.

 

HeiQ co-founder and CEO Carlo Centonze said:

 

"This contract demonstrates the significant market opportunity for HeiQ Viroblock beyond textiles, and with exclusivity only granted in India, there is potential to roll out the application of our award-winning antiviral technology in paint and coatings to different partners and territories. We are thrilled to have moved into this new US$150 billion material market alongside such a prestigious brand, which has built a strong industry reputation for being a first mover in establishing a number of trendsetting innovations. This builds on the success we have already experienced to date with our innovation, having already 'viroblocked' over a billion textile products since launching it a year ago.

 

"We are delighted that we can now viroblock homes and offices and make every surface safer to touch. It gives HeiQ satisfaction to know we are playing our part in enhancing the quality of people's lives, not just during the pandemic, but well into the future."

 

For further information, please contact:

 

HeiQ Plc

Carlo Centonze (CEO)

+41 56 250 68 50

Arlington Group Asset Management Limited (Financial Advisor and Joint Broker)

Charles Cannon Brookes

+44 (0) 207 389 5017

Cenkos Securities plc (Joint Broker)

Stephen Keys / Callum Davidson

+44 (0) 207 397 8900

SEC Newgate (Media Enquiries)

Elisabeth Cowell / Robin Tozer / Megan Kovach

+44 (0) 20 3757 6882

HeiQ@secnewgate.co.uk

 

About HeiQ

HeiQ is a pioneer and at the forefront of global technology in the $10 billion antimicrobial fabrics and $24 billion textile chemicals market. With the focus on materials and textile innovation, HeiQ has created some of the most effective, durable and high-performance technologies and textile effects in the market today, which cool, warm, dry, repel, purify, and destroy viruses. Since 2005, HeiQ has developed over 200 technologies in partnership with 300 major brands.

 

HeiQ is a high intellectual capital company which has successfully built up a reputation in textile technologies, having won multiple awards and innovating with leading eco-conscious brands such as Patagonia.

 

Led by an experienced management team, HeiQ rapidly researches new solutions for partners, quickly delivers scaled up manufacturing from its sites across the world and helps partners market the product to end consumers - aiming for lab to consumer in months.

 

HeiQ aims to deliver growth for its shareholders through a combination of increased sales of its core products and by entering additional lucrative markets through disruptive innovations.

 

 

About Berger

 

Berger Paints India Ltd. is the among the largest 15 Paint companies in the world, the 5th largest in Asia and also ranks among the largest paint companies of India. The company has consistently featured in Millward Brown's Brand ZTM most valuable top Indian brands report since inception and also features prominently in the list of Forbes India's Super 50 Companies.

 

The company has always been a first mover in establishing a number of trendsetting innovations starting with Color Bank Tinting Machines in the 1990's to services like Berger Express Painting and products like Silk Breathe Easy and Weathercoat Long Life which were launched in 2020.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGRDKKBBOBKDCND
12
Date   Source Headline
22nd Apr 20247:00 amRNSHeiQ Synbio Secures Ecolab Contract Win
16th Apr 20242:17 pmRNSHolding(s) in Company
28th Mar 20247:00 amRNSUnaudited Interim Results
18th Mar 202412:41 pmRNSHolding(s) in Company
15th Mar 20247:00 amRNSHolding(s) in Company
14th Mar 20241:23 pmRNSCompletion of Fundraising, PDMR & Audit Update
13th Mar 20242:26 pmRNSResult of General Meeting
12th Mar 20247:00 amRNSBoard Changes
23rd Feb 20247:00 amRNSResult of Retail Offer
16th Feb 20247:00 amRNSResult of Placing
15th Feb 20245:49 pmRNSRetail Offer
15th Feb 20245:46 pmRNSAcquisition, Fundraising, Trading Update & GM
6th Dec 20232:46 pmRNSAgreed Changes to Concert Party
4th Dec 20237:00 amRNSDirector/PDMR Dealing
1st Dec 20233:04 pmRNSResult of General Meeting
30th Nov 20237:06 amRNSStatement Confirming Settlement
27th Nov 20237:00 amRNSBoard Appointment
8th Nov 20237:00 amRNSNotice of General Meeting
3rd Nov 20239:14 amRNSHolding(s) in Company
3rd Nov 20237:05 amRNSHolding(s) in Company
31st Oct 20237:43 amRNSFiling of Annual Report & Restoration of Trading
31st Oct 20237:30 amRNSRestoration - HEIQ PLC
30th Oct 20237:01 amRNSInterim Results
30th Oct 20237:00 amRNSResults for year ended 31 December 2022
23rd Oct 20237:00 amRNSNotice of Results and Audit Update
29th Sep 20237:00 amRNSAccounts Update
6th Jul 20237:00 amRNSMAS Holdings invests in HeiQ AeoniQ
29th Jun 20232:16 pmRNSResult of AGM
29th Jun 20237:00 amRNSAGM Statement
6th Jun 20237:00 amRNSNotice of AGM
2nd May 20237:44 amRNSTemporary Suspension of Trading in Ordinary Shares
27th Apr 20233:55 pmRNSTemporary Suspension
13th Jan 20232:09 pmRNSUpdate re. admission of Consideration Shares
12th Jan 20237:00 amRNSCompletion of Acquisition
10th Jan 20237:00 amRNSDirector / PDMR Dealing
6th Jan 20237:00 amRNSDirector / PDMR Dealing
5th Jan 20237:03 amRNSDirector/PDMR Shareholding
4th Jan 20237:00 amRNSTrading Update and Acquisition
14th Dec 20227:00 amRNSIncreased interest in HeiQ Chrisal to 71%
2nd Dec 20227:00 amRNSAcquisition of Chem-Tex Laboratories, Inc
7th Nov 20227:00 amRNSChange of Auditor
10th Oct 20227:00 amRNSFiles Breach of Exclusive Agreement Complaint
13th Sep 20227:00 amRNSInterim Results
30th Aug 20227:00 amRNSNotice of H1 2022 Results and Presentation
8th Aug 202210:33 amRNSIssue of Equity and Total Voting Rights
29th Jun 202211:06 amRNSResult of AGM
14th Jun 20227:00 amRNSCommercial progress of HeiQ’s Hygiene technologies
18th May 20227:00 amRNSNotice of AGM
12th May 20227:00 amRNSPayment of Earnout Consideration
28th Apr 20227:00 amRNSResults for the year ended 31 December 2021
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.